uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

Go back to uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
UNIQURE (NASDAQ: QURE) Delayed: 44.87 +0.36 (0.81%)
Previous Close $44.51    52 Week High $22.79 
Open $44.27    52 Week Low $6.63 
Day High $45.75    P/E N/A 
Day Low $44.05    EPS $0.00 
Volume 323,191